Daiichi Sankyo: Weaker Yen Boosts Topline Growth
Daiichi Sankyo's President and CEO Hiroyuki Okuzawa highlighted that a weaker yen provides advantages for the pharmaceutical company's topline growth, particularly benefiting international revenues when converted back to yen. However, he acknowledged that the currency headwind also increases expenses for operations outside of Japan, creating a mixed impact on overall profitability.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- BloombergTrace: Center
Daiichi Sankyo: Weaker Yen Boosts Topline Growth
Daiichi Sankyo's President and CEO Hiroyuki Okuzawa highlighted that a weaker yen provides advantages for the pharmaceutical company's topline growth, particularly benefiting international revenues when converted back to yen. However, he acknowledged that the currency headwind also increases expenses for operations outside of Japan, creating a mixed impact on overall profitability.
Rate outletRead original
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending